Does RABEPRAZOLE Cause Malignant neoplasm progression? 21 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Malignant neoplasm progression have been filed in association with RABEPRAZOLE (Rabeprazole Sodium). This represents 0.2% of all adverse event reports for RABEPRAZOLE.
21
Reports of Malignant neoplasm progression with RABEPRAZOLE
0.2%
of all RABEPRAZOLE reports
4
Deaths
14
Hospitalizations
How Dangerous Is Malignant neoplasm progression From RABEPRAZOLE?
Of the 21 reports, 4 (19.0%) resulted in death, 14 (66.7%) required hospitalization, and 3 (14.3%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RABEPRAZOLE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does RABEPRAZOLE Cause?
Chronic kidney disease (4,773)
Renal failure (3,135)
Acute kidney injury (2,545)
End stage renal disease (1,295)
Tubulointerstitial nephritis (1,125)
Death (857)
Drug ineffective (732)
Dyspnoea (423)
Gastrooesophageal reflux disease (416)
Headache (387)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which RABEPRAZOLE Alternatives Have Lower Malignant neoplasm progression Risk?
RABEPRAZOLE vs RACECADOTRIL
RABEPRAZOLE vs RADIATION THERAPY
RABEPRAZOLE vs RADIUM RA-223 DICHLORIDE
RABEPRAZOLE vs RALOXIFENE
RABEPRAZOLE vs RALTEGRAVIR